Cyclerion Therapeutics Inc (CYCN) Stock Price, Quote, News & History

CYCNNASDAQ
$3.13
-0.05-1.57%
At close: May 12, 5:00 PM EST
$3.05
-0.13-4.09%
Pre-Market: 3:00 AM EST
Earnings: Q1 2026 Earnings were released on Tue May 12th, after the market close

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
-3.31M
Investing Cash Flow (TTM)
-
Financing Cash Flow (TTM)
3.32M
Free Cash Flow (TTM)
-3.31M
Capital Expenditure (TTM)
-
Net Change in Cash (TTM)
8.00K

Valuation Metrics

Enterprise Value
$10.31M
PE Ratio (TTM)
-
PE Ratio (FWD)
-
PEG Ratio (TTM)
-
PS Ratio (TTM)
4.80
PB Ratio (TTM)
1.49
Earnings Yield % (TTM)
-35.46%
Earnings Yield % (FWD)
-38.34%
EV / EBITDA (TTM)
-
Price / EBITDA (TTM)
-
Price / Free Cash Flow (TTM)
-
Book Value / Share
$2.10

Company Debt

Total Debt
-
LT Debt
-
LT Debt Issuance (TTM)
-
LT Debt Repayment (TTM)
-
Total Cash
$3.24M
Debt to Equity
-
Issuance of Debt (TTM)
-
Repayment of Debt (TTM)
-

Key Statistics

Open
-
Close
$3.13
Volume / Avg.
0 / 4.65M
Day Range
- - -
52 Wk Range
1.03 - 8.48
Market Cap
$11.61M
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
50
Short Interest
1.78%
Days to Cover
1

About

Sector
Health Care
Industry
Biotechnology
Cyclerion Therapeutics Inc is a clinical-stage biopharmaceutical company harnessing the power of soluble guanylate cyclase (sGC) pharmacology to discover, develop, and commercialize breakthrough treatments for serious and orphan diseases. The company...
Show More
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

FAQ

Q

How do I buy Cyclerion Therapeutics (CYCN) stock?

A

You can purchase shares of Cyclerion Therapeutics (NASDAQ:CYCN) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Cyclerion Therapeutics (CYCN) competitors?

A

There are no as such competitors for Cyclerion Therapeutics.

Q

What is the forecast, or price target, for Cyclerion Therapeutics (CYCN) stock?

A

There is no analysis for Cyclerion Therapeutics to provide a consensus price target.

Q

What is the current price for Cyclerion Therapeutics (CYCN)?

A

The stock price for Cyclerion Therapeutics (NASDAQ: CYCN) is $3.05 last updated May 13, 2026 at 7:42 PM EDT.

Q

Does Cyclerion Therapeutics (CYCN) pay a dividend?

A

There are no upcoming dividends for Cyclerion Therapeutics.

Q

When is Cyclerion Therapeutics (NASDAQ:CYCN) reporting earnings?

A

Cyclerion Therapeutics does not have any upcoming earnings scheduled.

Q

Is Cyclerion Therapeutics (CYCN) going to split?

A

There is no upcoming split for Cyclerion Therapeutics.

Q

What sector and industry does Cyclerion Therapeutics (CYCN) operate in?

A

Cyclerion Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.